Areas of Interest
Clinical Translation, Investigational New Drugs, FDA, Research Operations
Dr. Morrison’s primary research interest is translation of basic and translational findings and discoveries from the bench into early phase clinical trials. She leads the office responsible for the oversight of LCCC’s clinical development program that includes investigator-initiated trials using investigational drugs/biologics provided by pharmaceutical partners, and UNC developed and/or manufactured investigational products. Her research interests focus on regulatory strategy, FDA interactions, clinical protocol development and patient education with a focus on developing clinical trials that are operationally feasible, data driven and patient friendly.
Education and Training
- Undergraduate University of North Carolina at Chapel Hill
- PhD Brody School of Medicine at East Carolina University
Working in clinical development/regulatory affairs is like being an aeronautical engineer working with an astronomer. The astronomer (bench scientist or clinician) discovers the bright new star in the sky and the engineer (regulatory professional) helps the astronomer get safely to the moon and back, building the blocks to someday make it to that star. That is why I love oncology research; we are continuously finding new “star” ideas and finding ways to get there to improve and save the lives of our patients.